Vivanza Biosciences Limited (BOM:530057)
India · Delayed Price · Currency is INR 1.480
+0.050 (3.50%)
At close: Nov 6, 2026
Vivanza Biosciences Market Cap
Vivanza Biosciences has a market cap or net worth of 59.2 million as of November 6, 2026. It is the 50,085th most valuable company in the world and the 5,445th biggest in India. Its market cap has decreased by 24.87% in one year.
Market Cap
59.20M
Enterprise Value
160.47M
Revenue
1.17B
Global Rank
Country Rank
#5,445 India
PE Ratio
12.30
ChartMarket Cap Chart
Since October 23, 2012, Vivanza Biosciences's market cap has decreased from 178.64M to 59.20M, a decrease of -66.86%. That is a compound annual growth rate of -7.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 59.20M | -32.73% |
| Dec 31, 2025 | 88.00M | -35.67% |
| Dec 31, 2024 | 136.80M | -68.25% |
| Dec 29, 2023 | 430.80M | -30.96% |
| Dec 23, 2022 | 624.00M | -12.92% |
| Dec 27, 2021 | 716.60M | 59.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Desh Rakshak Aushdhalaya | 139.61M |
| Unjha Formulations | 129.89M |
| Beryl Drugs | 126.79M |
| Emmessar Biotech & Nutrition | 112.41M |
| Ortin Global | 105.71M |
| Ganga Pharmaceuticals | 73.89M |
| Brawn Biotech | 66.31M |
| Decipher Labs | 58.48M |